The results of this experiment confirm that Phylogica’s Cell Penetrating Phylomers (CPPs) can provide access to intracellular drug targets in animals. With this proof of concept the Company’s future focus will be on:
establishing the efficacy of Phylogica’s own proprietary cargoes against high value intracellular targets
PYC Price at posting:
1.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)